DK1971361T3 - Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom - Google Patents

Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Info

Publication number
DK1971361T3
DK1971361T3 DK06847924.5T DK06847924T DK1971361T3 DK 1971361 T3 DK1971361 T3 DK 1971361T3 DK 06847924 T DK06847924 T DK 06847924T DK 1971361 T3 DK1971361 T3 DK 1971361T3
Authority
DK
Denmark
Prior art keywords
glycoforms
enhanced
treatment
metabolic syndrome
stimulating hormone
Prior art date
Application number
DK06847924.5T
Other languages
English (en)
Inventor
James D Kelly
Original Assignee
James D Kelly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James D Kelly filed Critical James D Kelly
Application granted granted Critical
Publication of DK1971361T3 publication Critical patent/DK1971361T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK06847924.5T 2005-12-23 2006-12-21 Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom DK1971361T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75379805P 2005-12-23 2005-12-23
PCT/US2006/048820 WO2007075906A2 (en) 2005-12-23 2006-12-21 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome

Publications (1)

Publication Number Publication Date
DK1971361T3 true DK1971361T3 (da) 2014-09-08

Family

ID=38218620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06847924.5T DK1971361T3 (da) 2005-12-23 2006-12-21 Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Country Status (7)

Country Link
US (1) US9333241B2 (da)
EP (1) EP1971361B1 (da)
JP (1) JP5727693B2 (da)
AU (1) AU2006331619B2 (da)
CA (1) CA2631948A1 (da)
DK (1) DK1971361T3 (da)
WO (1) WO2007075906A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971361T3 (da) 2005-12-23 2014-09-08 James D Kelly Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom
US8741259B2 (en) 2008-10-20 2014-06-03 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
US9206154B2 (en) 2010-04-08 2015-12-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inverse agonists and neutral antagonists for the TSH receptor
KR101789509B1 (ko) * 2015-11-05 2017-10-26 주식회사 프로젠 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법
CN115975056B (zh) * 2023-02-07 2023-12-01 徐州医科大学 利用天然蛋白tsh作为抗原结合位点构建靶向tshr的car-t细胞

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0228604A3 (en) 1985-12-11 1988-10-12 Sloan-Kettering Institute For Cancer Research Isolation of a gene encoding human thyrotropin beta subunit
CN1277633A (zh) 1997-09-22 2000-12-20 马里兰大学巴尔的摩分校 促甲状腺激素的突变体及其制备方法
ES2558160T3 (es) 1998-12-09 2016-02-02 Phyton Holdings, Llc Glicoproteínas que tienen glicosilación de tipo humano
US7514239B2 (en) 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
US20030219786A1 (en) 2000-08-11 2003-11-27 Applied Research Systems Ars Holding N.V. Novel glycoproteins and methods of use thereof
CA2454181A1 (en) 2001-07-13 2003-01-23 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to induce lipolysis
JP2005529171A (ja) 2002-06-10 2005-09-29 ザイモジェネティクス，インコーポレイティド 炎症を処理し、そしてグルココルチコイド作用を強化するためへのコルチコトロフ由来の糖タンパク質ホルモンの使用
US20040138116A1 (en) * 2002-08-30 2004-07-15 Vincent Geenen Tolerogenic approach for type 1 diabetes
US20050096264A1 (en) 2003-02-25 2005-05-05 Macdonald Lynn Methods for treating obesity and related conditions with glycoprotein hormone beta family hormones
CA2517896A1 (en) * 2003-03-05 2004-09-16 Zymogenetics, Inc. Use of thyroid-stimulating hormone to induce lipolysis
CA2545160A1 (en) 2003-11-06 2005-05-19 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
JP2007513191A (ja) 2003-12-05 2007-05-24 ザイモジェネティクス，インコーポレイティド 甲状腺刺激ホルモンを用いての炎症の処理方法
US20050250185A1 (en) 2003-12-12 2005-11-10 Murphy Andrew J OGH fusion polypeptides and therapeutic uses thereof
DE602005022675D1 (de) * 2004-02-04 2010-09-16 Centre Nat Rech Scient Verfahren zur identifizierung von glykoformspezifischen antikörpern
CA2555908A1 (en) * 2004-03-05 2005-09-22 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to treat liver steatosis
DK1971361T3 (da) 2005-12-23 2014-09-08 James D Kelly Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Also Published As

Publication number Publication date
US20100210512A1 (en) 2010-08-19
JP5727693B2 (ja) 2015-06-03
WO2007075906A2 (en) 2007-07-05
EP1971361B1 (en) 2014-06-04
JP2009525264A (ja) 2009-07-09
AU2006331619B2 (en) 2012-12-20
US9333241B2 (en) 2016-05-10
AU2006331619A1 (en) 2007-07-05
WO2007075906A3 (en) 2009-09-03
EP1971361A4 (en) 2010-08-18
CA2631948A1 (en) 2007-07-05
EP1971361A2 (en) 2008-09-24

Similar Documents

Publication Publication Date Title
PL4098247T3 (pl) Stabilizowane postacie użytkowe zawierające przeciwciała przeciwko receptorowi interleukiny 6 (il-6r)
PT2059535E (pt) Anticorpos específicos do prlr e suas utulizações
DK2046819T3 (da) Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
EP2423194A4 (en) NEW THYROID HORMONE-β-RECEPTOR AGONIST
DK1844070T3 (da) Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet
DK2478896T3 (da) Brudsikre doseringsforme med forsinket frigivelse
DK1919878T3 (da) Pyridazinonderivater som thyroidhormonreceptoragonister
HK1220383A1 (zh) 用於治疗肥胖症的聚乙二醇化的胰高血糖素和glp-1共激动剂
DK2129654T3 (da) Antagonister af glucagonreceptoren
TWI370135B (en) Analogs of ghrelin substituted at the n-terminal
DK2038423T3 (da) Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet
NO20084339L (no) Stabiliserte polypeptidsammensetninger
DK2959894T3 (da) S1p-receptormodulatorer til behandling af multipel sklerose
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
IS8596A (is) Mótefni gegn CD154
PL2018184T3 (pl) Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
HUE038279T2 (hu) Klotho-béta-agonista antitest cukorbetegség vagy inzulinrezisztencia kezelésében történõ alkalmazásra
DK2227243T3 (da) Farmaceutisk sammensætning til behandling af obesitet relaterede sygdomme, omfattende et insulinotropisk peptidkonjugat
BRPI0820535A2 (pt) composições farmacêuticas contendo insulina e um peptídeo insulinotrópico
ATE516853T1 (de) Zyklische peptid-cxcr4-antagonisten
BRPI0809931A2 (pt) Antagonistas do receptor do hormônio liberador de gonadotrofina e métodos relacionados com o mesmo
DK1986642T3 (da) Kombination af alfa-2-receptoragonist (clonidin) og et antimuscarinmiddel (oxybutynin) til behandling af sialorrhoea
DK1917253T3 (da) Fremgangsmåde til fremstilling af betamimetika
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
DK1959988T3 (da) Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder